Strategies implemented for accurate dispensing of an investigational new drug in a multi-site HIV prevention clinical trial

Safe practices for dispensing investigational product (IP) during clinical trials are not standardized and information in this regard is often limited. ASPIRE was a Phase 3 safety and effectiveness trial of a vaginal matrix ring containing 25 mg of dapivirine for the prevention of HIV-1 in women. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Cindy, Moodley, Jayajothi, Bhoola, Aruna, Sakwa, Rebecca, Moodley, Jeeva, Sukdao, Jasmin, Hurbans, Nivriti, Maharaj, Bhavna, Naidoo, Anushka, Maclachlan, Melanie, Chareka, Gift, Hlahla, Kudzai, Chadza, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605196/
https://www.ncbi.nlm.nih.gov/pubmed/34825101
http://dx.doi.org/10.1016/j.conctc.2021.100859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605196/
https://www.ncbi.nlm.nih.gov/pubmed/34825101
http://dx.doi.org/10.1016/j.conctc.2021.100859

Ejemplares similares